Drug Des Devel Ther
Physician-Supervised Peptide and GLP-1 Therapy Combining BPC-157 with GLP-1 medications is a practical approach to addressing both weight management and tissue health through complementary pathways
An interesting point would be the use of the same dose range in BPC 157 studies [1,2,3,4,5,6,7,8,9,10,11]
Prescribing of AOM tirzepatide (brand name Zepbound) was observed in the first month of availability in pharmacies, December 2023
Needed a reset, met with Luke and very happy to revisit in person today
The experiment met the requirements of animal ethics with IRB no